![Matthew Young](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Young
Direktor/Vorstandsmitglied bei
CYTOMX THERAPEUTICS, INC.
Vermögen: - $ am 31.05.2026
Profil
Matthew P.
Young is currently Lead Independent Director at CytomX Therapeutics, Inc. since 2018, Managing Director at Longitude Capital Management Co LLC since 2022, and Director at Orsobio, Inc. Former roles include Managing Director at Lehman Brothers, Inc. from 2003 to 2007, Independent Director at PRA Health Sciences, Inc. from 2015 to 2021, Treasurer & Director at Jazz Pharmaceuticals Therapeutics, Inc., Managing Director at Citigroup Global Markets, Inc. from 2007 to 2008, Managing Director-Global Healthcare at Barclays Capital, Inc. from 2009 to 2013, Director at Merrill Lynch & Co., Inc. from 1994 to 2003, Chief Financial Officer & Executive Vice President at Jazz Pharmaceuticals Plc from 2015 to 2019, and Chief Operating Officer & Chief Financial Officer at GRAIL, Inc. from 2019 to 2021.
Education includes an undergraduate degree (1991) and an MBA (1992) from The Wharton School of the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.04.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Matthew Young
| Unternehmen | Position | Beginn |
|---|---|---|
| CYTOMX THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.09.2015 |
Longitude Capital Management Co LLC
 Longitude Capital Management Co LLC Investment ManagersFinance Longitude Capital invests in both private and public companies located in the United States. The firm targets companies operating in the fields of medical technology, biotechnology and health solutions. It participates in early stage capital requirements. | Private Equity Investor | 01.08.2022 |
OrsoBio Inc
 OrsoBio Inc Miscellaneous Commercial ServicesCommercial Services Develops therapies to treat metabolic disorders and diabetes | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Matthew Young
| Unternehmen | Position | Ende |
|---|---|---|
| GRAIL, INC. | Finanzdirektor/CFO | 01.12.2021 |
| PRA HEALTH SCIENCES, INC. | Direktor/Vorstandsmitglied | 01.07.2021 |
| JAZZ PHARMACEUTICALS PLC | Finanzdirektor/CFO | 25.10.2019 |
Barclays Capital, Inc.
 Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01.04.2013 |
Citigroup Global Markets, Inc.
 Citigroup Global Markets, Inc. Investment Banks/BrokersFinance Provides investment banking, financial and wealth management services | Corporate Officer/Principal | 01.01.2008 |
Ausbildung von Matthew Young
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
98
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
PRA Health Sciences, Inc.
 PRA Health Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research and development services for pharmaceutical & biotechnology companies | Commercial Services |
Citigroup Global Markets, Inc.
Citigroup Global Markets, Inc. Investment Banks/BrokersFinance Provides investment banking, financial and wealth management services | Finance |
Celator Pharmaceuticals, Inc.
 Celator Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat acute myeloid leukemia and AML with myelodysplasia in children & adults | Health Technology |
Barclays Capital, Inc.
Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Longitude Capital Management Co LLC
Longitude Capital Management Co LLC Investment ManagersFinance Longitude Capital invests in both private and public companies located in the United States. The firm targets companies operating in the fields of medical technology, biotechnology and health solutions. It participates in early stage capital requirements. | Finance |
Jazz Pharmaceuticals Plc
 Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
Merrill Lynch & Co., Inc.
 Merrill Lynch & Co., Inc. Investment ManagersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services | Finance |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytomX Therapeutics, Inc.
 CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
GRAIL, Inc.
 GRAIL, Inc. Medical SpecialtiesHealth Technology Manufactures cancer detection test kits and provides related services | Health Technology |
OrsoBio Inc
OrsoBio Inc Miscellaneous Commercial ServicesCommercial Services Develops therapies to treat metabolic disorders and diabetes | Commercial Services |
